Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancer
暂无分享,去创建一个
S. Maheswaran | Jeffrey E. Green | P. Walden | E. Brachtel | H. Kawakubo | J. L. Carey | Vandana Gupta
[1] S. Maheswaran,et al. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells , 2003, Molecular and Cellular Endocrinology.
[2] Richard Simon,et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Melamed,et al. Expression of B-cell translocation gene 2 protein in normal human tissues. , 2002, Tissue & cell.
[4] T. Soussi,et al. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. , 2002, Gene.
[5] P. Donahoe,et al. Mullerian-inhibiting substance regulates NF–κB signaling in the prostate in vitro and in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Rubin,et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. , 2001, Carcinogenesis.
[7] P. Donahoe,et al. Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo* , 2001, The Journal of Biological Chemistry.
[8] P. Donahoe,et al. Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway* , 2000, The Journal of Biological Chemistry.
[9] Cheryl Jorcyk,et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma , 2000, Oncogene.
[10] P. Hainaut,et al. BTG gene expression in the p53‐dependent and ‐independent cellular response to DNA damage , 2000, Molecular carcinogenesis.
[11] Christian Kaltschmidt,et al. Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators , 1999, Oncogene.
[12] W. Huttner,et al. Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] T. Park,et al. Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin‐dependent kinase 4 proteins due to overexpression of TIS21 , 1998, Molecular carcinogenesis.
[14] J. Magaud,et al. Interaction of BTG1 and p53-regulatedBTG2 Gene Products with mCaf1, the Murine Homolog of a Component of the Yeast CCR4 Transcriptional Regulatory Complex* , 1998, The Journal of Biological Chemistry.
[15] T. Park,et al. Enzymatic methylation of recombinant TIS21 protein‐arginine residues , 1998, Biochemistry and molecular biology international.
[16] D. Baltimore,et al. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. , 1997, Immunity.
[17] S. Clarke,et al. The Mammalian Immediate-early TIS21 Protein and the Leukemia-associated BTG1 Protein Interact with a Protein-arginine N-Methyltransferase* , 1996, The Journal of Biological Chemistry.
[18] N. Colburn,et al. Preferential primary‐response gene expression in promotion‐resistant versus promotion‐sensitive JB6 cells , 1994, Molecular carcinogenesis.
[19] Emma Lees,et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.
[20] S. van den Heuvel,et al. Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.
[21] P. Donahoe,et al. Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects. , 1992, Protein expression and purification.
[22] E. Shooter,et al. Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[24] L. Chen,et al. Loss of heterozygosity on chromosome 1q in human breast cancer. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] N. Kim,et al. Experimental Oncology Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines , 2005, Journal of Cancer Research and Clinical Oncology.